Detail Katalog
ID: 3250
Merck Druggernaunt : the Inside Story of a Pharmaceutical Giant / Fran Howthorne
Pengarang:
Howthorne, Fran
Howthorne, Fran
Penerbit:
John Wiley & Sons,
John Wiley & Sons,
Tempat Terbit:
New Jersey :
New Jersey :
Tahun Terbit:
2003
2003
Bahasa:
eng
eng
Subjek
Merck & Co -- Pharmaceutical Industry-United States
Deskripsi Fisik:
xiv, 290 p. ; 22 cm.
xiv, 290 p. ; 22 cm.
ISBN:
0-471-22878-8
0-471-22878-8
Nomor Panggil:
338.70973 HOW m
338.70973 HOW m
Control Number:
INLIS000000000003250
INLIS000000000003250
BIB ID:
0010-0520003250
0010-0520003250
Catatan
Indeks : p. 282-290 ; p. 279-282 ; An in--depth look at big pharma's flagship company This book takes readers inside Merck, the world's second most profitable drug company and maker of the world's bestselling drug, Prilosec. Consistently named one of Fortune magazine's Most Admired Companies, Merck struggles to maintain its reputation for being the most ethical of the big drug makers, refusing to slash research and development budgets in the face of declining profits, falling stock market prices, and questionable accounting. Author the one of the leading journalists covering healthcare, has written an excellent examination of a business paragon with much--needed insight on the cutthroat world of pharmaceuticals. It's a story that will interest the business world as well as consumer and healthcare advocates by detailing the vital issues in medicine and healthcare today. More than just a compelling story of success in a difficult industry, more than simply the biography of one of big business's most recognizable names.
Status
Tersedia di OPAC
Bibliografi Nasional Indonesia
Karya Tulis Ilmiah Nasional
Informasi Eksemplar & Metadata
| Nomor Barcode | Nomor Panggil | Akses | Lokasi | Ketersediaan |
|---|---|---|---|---|
00000011227 |
338.70973 HOW m |
Dapat dipinjam | Mahkamah Konstitusi RI | Tersedia |
00000011228 |
338.70973 HOW m |
Dapat dipinjam | Mahkamah Konstitusi RI | Tersedia |
Format MARC21 - Total 23 field
| Tag | Ind1 | Ind2 | Nilai | Urutan |
|---|---|---|---|---|
| 001 | _ |
_ |
INLIS000000000003250 | 1 |
| 005 | _ |
_ |
20221026100548 | 2 |
| 035 | # |
# |
$a 0010-0520003250 | 3 |
| 008 | _ |
_ |
221026################|##########|#eng## | 4 |
| 020 | # |
# |
$a 0-471-22878-8 | 5 |
| 041 | _ |
_ |
$a eng | 6 |
| 082 | # |
# |
$a 338.70973 | 7 |
| 084 | # |
# |
$a 338.70973 HOW m | 8 |
| 100 | _ |
# |
$a Howthorne, Fran | 9 |
| 245 | 1 |
4 |
$a Merck Druggernaunt : $b the Inside Story of a Pharmaceutical Giant /$c Fran Howthorne | 10 |
| 260 | # |
# |
$a New Jersey :$b John Wiley & Sons,$c 2003 | 11 |
| 300 | # |
# |
$a xiv, 290 p. ; $c 22 cm. | 12 |
| 500 | # |
# |
$a Indeks : p. 282-290 | 13 |
| 504 | # |
# |
$a p. 279-282 | 14 |
| 520 | # |
# |
$a An in--depth look at big pharma's flagship company This book takes readers inside Merck, the world's second most profitable drug company and maker of the world's bestselling drug, Prilosec. Consistently named one of Fortune magazine's Most Admired Companies, Merck struggles to maintain its reputation for being the most ethical of the big drug makers, refusing to slash research and development budgets in the face of declining profits, falling stock market prices, and questionable accounting. Author the one of the leading journalists covering healthcare, has written an excellent examination of a business paragon with much--needed insight on the cutthroat world of pharmaceuticals. It's a story that will interest the business world as well as consumer and healthcare advocates by detailing the vital issues in medicine and healthcare today. More than just a compelling story of success in a difficult industry, more than simply the biography of one of big business's most recognizable names. | 15 |
| 650 | _ |
4 |
$a Merck & Co | 16 |
| 650 | _ |
4 |
$a Pharmaceutical Industry-United States | 17 |
| 990 | # |
# |
$a 11227/MKRI-P/XII-2008 | 18 |
| 990 | # |
# |
$a 11228/MKRI-P/XII-2008 | 19 |
| 990 | # |
# |
$a 11227/MKRI-P/XII-2008 | 20 |
| 990 | # |
# |
$a 11228/MKRI-P/XII-2008 | 21 |
| 990 | # |
# |
$a 11228/MKRI-P/XII-2008 | 22 |
| 990 | # |
# |
$a 11227/MKRI-P/XII-2008 | 23 |
Penjelasan Field MARC21:
- 001: Control Number
- 005: Date and Time of Latest Transaction
- 020: ISBN
- 100: Main Entry - Personal Name
- 245: Title Statement
- 250: Edition Statement
- 260: Publication Information
- 300: Physical Description
- 650: Subject
- 700: Added Entry - Personal Name
Aksi Cepat
Informasi Katalog
Ditambahkan: 30 Dec 2008
Disetujui OPAC: 08 May 2020
Disetujui OPAC: 08 May 2020